# BATF and BATF3 deficiency alters CD8+ effector/exhausted T cells balance in skin transplantation

**Authors:** Chenghao Li, Zongtao Liu, Zihao Wang, Wai Yen Yim, Yajun Huang, Yuqi Chen

PMC · DOI: 10.1186/s10020-024-00792-0 · 2024-01-31

## TL;DR

This study shows that lacking BATF and BATF3 proteins in CD8+ T cells reduces their activity and improves skin transplant survival in mice.

## Contribution

The study reveals a novel role of BATF and BATF3 in regulating CD8+ T cell differentiation and exhaustion in the context of transplantation.

## Key findings

- BATF and BATF3 deficiency promotes long-term survival of skin allografts.
- Deficiency in BATF and BATF3 reduces CD8+ T cell allo-response and cytokine secretion.
- BATF and BATF3 deficiency leads to the generation of exhausted CD8+ T cells.

## Abstract

It is well-established that CD8+ T-cells play a critical role in graft rejection. The basic leucine zipper ATF-like transcription factor (BATF) and BATF3 are transcriptional factors expressed in T lymphocytes. Herein, we investigated the functions of BATF and BATF3 in the differentiation and exhaustion of CD8+ T cells following alloantigen activation.

Wild-type CD8+ T cells, BATF-deficient (Batf−/−) CD8+ T cells, and CD8+ T cells deficient in both BATF and BATF3 (Batf−/−Batf3−/−) were transferred to B6.Rag1−/− mice, which received skin allografts from BALB/c mice. Flow cytometry was conducted to investigate the number of CD8+ T cells and the percentage of effector subsets.

BATF expression positively correlated with effector CD8+ T cell differentiation. BATF and BATF3 deficiency promoted skin allograft long-term survival and attenuated the CD8+ T cell allo-response and cytokine secretion. Finally, BATF and BATF3 deficiency prompted the generation of exhausted CD8+ T cells.

Overall, our findings provide preliminary evidence that both BATF and BATF3 deficiency influences the differentiation of effector CD8+ T cells and mediates the exhaustion of CD8+ T cells, prolonging transplant survival. Targeting BATF and BATF3 to inhibit CD8+ T cell function has huge prospects for application as a therapeutic approach to prevent transplant rejection.

The online version contains supplementary material available at 10.1186/s10020-024-00792-0.

## Linked entities

- **Genes:** BATF (basic leucine zipper ATF-like transcription factor) [NCBI Gene 10538], BATF3 (basic leucine zipper ATF-like transcription factor 3) [NCBI Gene 55509]

## Full-text entities

- **Genes:** Cd3e (CD3 antigen, epsilon polypeptide) [NCBI Gene 12501] {aka CD3, CD3epsilon, T3e}, Mki67 (antigen identified by monoclonal antibody Ki 67) [NCBI Gene 17345] {aka D630048A14Rik, Ki-67, Ki67}, Btla (B and T lymphocyte associated) [NCBI Gene 208154] {aka A630002H24}, Il2 (interleukin 2) [NCBI Gene 16183] {aka Il-2}, Cd4 (CD4 antigen) [NCBI Gene 12504] {aka L3T4, Ly-4}, Cd28 (CD28 antigen) [NCBI Gene 12487], Cd44 (CD44 antigen) [NCBI Gene 12505] {aka HERMES, Ly-24, Pgp-1}, Tcrb (T cell receptor beta chain) [NCBI Gene 21577] {aka TCRbeta, Tib}, Foxp3 (forkhead box P3) [NCBI Gene 20371] {aka JM2, scurfin, sf}, Ifng (interferon gamma) [NCBI Gene 15978] {aka IFN-g, If2f, Ifg}, Il7r (interleukin 7 receptor) [NCBI Gene 16197] {aka CD127, IL-7Ralpha}, Tcf7 (transcription factor 7, T cell specific) [NCBI Gene 21414] {aka TCF-1, Tcf1}, TBX21 (T-box transcription factor 21) [NCBI Gene 100518804] {aka T-bet}, Fosl1 (fos-like antigen 1) [NCBI Gene 14283] {aka Fra1, fra-1}, Batf3 (basic leucine zipper transcription factor, ATF-like 3) [NCBI Gene 381319] {aka 9130211I03Rik, Snft}, Tbx21 (T-box 21) [NCBI Gene 57765] {aka TBT1, Tbet, Tblym}, Fos (Fos proto-oncogene, AP-1 transcription factor subunit) [NCBI Gene 14281] {aka D12Rfj1, c-fos, cFos}, Atf3 (activating transcription factor 3) [NCBI Gene 11910] {aka LRG-21}, Batf2 (basic leucine zipper transcription factor, ATF-like 2) [NCBI Gene 74481] {aka B-ATF-2}, Rag1 (recombination activating 1) [NCBI Gene 19373] {aka Rag-1}, Ikzf2 (IKAROS family zinc finger 2) [NCBI Gene 22779] {aka A730095J18Rik, Helios, Zfpn1a2, Znfn1a2}, Tox (thymocyte selection-associated high mobility group box) [NCBI Gene 252838] {aka 1700007F02Rik}, Ptprc (protein tyrosine phosphatase receptor type C) [NCBI Gene 19264] {aka B220, CD45R, Cd45, L-CA, Ly-5, Lyt-4}, HNF1A (HNF1 homeobox A) [NCBI Gene 574067] {aka HNF-1, TCF1}, EOMES [NCBI Gene 100524218], Sell (selectin, lymphocyte) [NCBI Gene 20343] {aka CD62L, L-selectin, LAM-1, LECAM-1, LECAM1, Lnhr}, Im7 (immunoregulatory 7) [NCBI Gene 100035768] {aka LCH18}, Irf4 (interferon regulatory factor 4) [NCBI Gene 16364] {aka IRF-4, LSIRF, NF-EM5, Spip}, Dnajc12 (DnaJ heat shock protein family (Hsp40) member C12) [NCBI Gene 30045] {aka Jdp1, mJDP1}, Gzmb (granzyme B) [NCBI Gene 14939] {aka CCP-1/C11, CCP1, Ctla-1, Ctla1, GZB}, Jun (Jun proto-oncogene, AP-1 transcription factor subunit) [NCBI Gene 16476] {aka AP-1, Junc, c-jun}, Jund (jun D proto-oncogene, AP-1 transcription factor subunit) [NCBI Gene 16478] {aka Jund1}, Klrg1 (killer cell lectin-like receptor subfamily G, member 1) [NCBI Gene 50928] {aka 2F1-Ag, MAFA, MAFA-L}, Lag3 (lymphocyte-activation gene 3) [NCBI Gene 16768] {aka CD223, LAG-3, Ly66}, Trav6-3 (T cell receptor alpha variable 6-3) [NCBI Gene 328483] {aka Gm13948, Gm193, Gm4, TCR}, Cxcr3 (C-X-C motif chemokine receptor 3) [NCBI Gene 12766] {aka Cd183, Cmkar3}, Tnf (tumor necrosis factor) [NCBI Gene 21926] {aka DIF, TNF-a, TNF-alpha, TNFSF2, TNFalpha, Tnfa}, Fosl2 (fos-like antigen 2) [NCBI Gene 14284] {aka Fra-2}, Entpd1 (ectonucleoside triphosphate diphosphohydrolase 1) [NCBI Gene 12495] {aka 2610206B08Rik, ATP-DPH, Cd39, E130009M23Rik, NTPDase-1}, Junb (jun B proto-oncogene, AP-1 transcription factor subunit) [NCBI Gene 16477], Batf (basic leucine zipper transcription factor, ATF-like) [NCBI Gene 53314] {aka B-ATF, SFA-2}, Jdp2 (Jun dimerization protein 2) [NCBI Gene 81703] {aka Jundm2, Jundp2, TIF}
- **Diseases:** inflammatory (MESH:D007249), BATF deficiency (MESH:D007153), vasculitis (MESH:D014657), pain (MESH:D010146), infection (MESH:D007239), allograft injury (MESH:D000092122), cancer (MESH:D009369), viral (MESH:D014777), necrosis (MESH:D009336), bacterial infections (MESH:D001424)
- **Chemicals:** Brefeldin A (MESH:D020126), hematoxylin (MESH:D006416), paraffin (MESH:D010232), eosin (MESH:D004801), TRIzol (MESH:C411644), formalin (MESH:D005557), H&amp;E (MESH:D006371)
- **Species:** Mus musculus (house mouse, species) [taxon 10090], Homo sapiens (human, species) [taxon 9606]
- **Cell lines:** MP6 — Mus musculus (Mouse), Hybridoma (CVCL_A0RL), BALB/c — Mus musculus (Mouse), Spontaneously immortalized cell line (CVCL_0184), C57BL/6 — Mus musculus (Mouse), Transformed cell line (CVCL_C0MU), JES6-5H4 — Mus musculus (Mouse), Hybridoma (CVCL_9187), XMG1.2 — Mus musculus (Mouse), Hybridoma (CVCL_2H37), H57 — Rattus norvegicus (Rat), Hybridoma (CVCL_D667), S2 — Drosophila melanogaster (Fruit fly), Spontaneously immortalized cell line (CVCL_Z232)

## Figures

7 figures with captions in the complete paper: https://tomesphere.com/paper/PMC10832090/full.md

---
Source: https://tomesphere.com/paper/PMC10832090